Avandia FDA panel diabetes drug

Avandia fell from its perch atop the diabetes drug market amid safety concerns.
Justin Sullivan / Getty Images
Copyright © 2018, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad
63°